LifeGene is a national collaborative project designed to build up a resource for research in all medical disciplines, enabling new and groundbreaking research on the relationships among heredity, environment and lifestyle. The study will include studying several hundred thousand Swedes over a long period of time with the aim of creating new tools to prevent, diagnose and treat our most common diseases.
LifeGene will constitute a platform for a myriad of biomedical research projects. Researchers not only in biomedicine and biotechnology but also behavioral and social sciences may benefit from access to LifeGene. By combining a biological perspective with e-epidemiology, LifeGene will open up new possibilities for a greater understanding of the interplay between heredity, lifestyle and the environment as regards to our most common diseases.
By the end of 2015 LifeGene consisted of data from more than 45 000 individuals with more than 72 000 questionnaires and physical data, as well as biological samples and DNA, from more than 26 000 individuals.
By the end of 2015 LifeGene had completed nine withdrawals from a wide research spectrum and there are more in the pipeline. LifeGene welcomes research applications and request for withdrawals from all medical disciplines and behavioral sciences.
Startup funding was received from Karolinska Institutet, the Stockholm County Council and the Swedish Research Council as well as Torsten and Ragnar Söderbergs foundation and AFA Försäkring.
LifeGene is today operating in cooperation with Stockholm County Council. The goal is to reach 250,000 participants throughout Sweden but that would require that more counties and stakeholders become aware of and interested in cooperating with LifeGene.
– We have so much amazing data available to make withdrawals from but to achieve the goal of 250 000 participants we need further collaborations, says Kicki Kjaeergard CEO of LifeGene.